How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?
- PMID: 36252166
- PMCID: PMC9812475
- DOI: 10.1200/GO.22.00156
How Can Genomic Innovations in Pediatric Brain Tumors Transform Outcomes in Low- and Middle-Income Countries?
Erratum in
-
Erratum.JCO Glob Oncol. 2023 Jan;9:e2200400. doi: 10.1200/GO.22.00400. JCO Glob Oncol. 2023. PMID: 36608307 Free PMC article. No abstract available.
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
No other potential conflicts of interest were reported.
Figures
References
-
- Lam CG, Howard SC, Bouffet E, Pritchard-Jones K: Science and health for all children with cancer. Science 363:1182-1186, 2019 - PubMed
-
- Seah T, Zhang C, Halbert J, et al. : The magnitude and predictors of therapy abandonment in pediatric central nervous system tumors in low- and middle-income countries: Systematic review and meta-analysis. Pediatr Blood Cancer 66:e27692, 2019 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
